Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 14 March 1980:
Vol. 207. no. 4436, pp. 1214 - 1216
DOI: 10.1126/science.7355283
Prev | Table of Contents | Next

Articles

Science, Vol 207, Issue 4436, 1214-1216
Copyright © 1980 by American Association for the Advancement of Science

articles

Artificial sweetener use and bladder cancer: a case-control study

EL Wynder and SD Stellman

In a case-control study of 302 male and 65 female bladder cancer patients and an equal number of other patients matched to them in age, sex, hospital, and hospital-room status, no association was found between use of artificial sweeteners or diet beverages and bladder cancer. No dose-response was observed with respect to quantity or duration of use of the two combined. No evidence was found to suggest that artificial sweeteners or diet beverages promote the tumorigenic effect of tobacco smoking. Artificial sweetener and diet beverage use strongly reflected socioeconomic status among controls with various diagnoses.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Artificial Sweeteners and the Risk of Gastric, Pancreatic, and Endometrial Cancers in Italy.
C. Bosetti, S. Gallus, R. Talamini, M. Montella, S. Franceschi, E. Negri, and C. La Vecchia (2009)
Cancer Epidemiol. Biomarkers Prev. 18, 2235-2238
   Abstract »    Full Text »    PDF »
Artificial sweeteners and cancer risk in a network of case-control studies.
S Gallus, L Scotti, E Negri, R Talamini, S Franceschi, M Montella, A Giacosa, L Dal Maso, and C La Vecchia (2007)
Ann. Onc. 18, 40-44
   Abstract »    Full Text »    PDF »
Artificial sweeteners--do they bear a carcinogenic risk?.
M. R. Weihrauch and V. Diehl (2004)
Ann. Onc. 15, 1460-1465
   Abstract »    Full Text »    PDF »
Hyperinsulinemic hypoalphalipoproteinemia as a new indicator for coronary heart disease.
K. Saku, B. Zhang, K. Shirai, S. Jimi, K. Yoshinaga, and K. Arakawa (1999)
J. Am. Coll. Cardiol. 34, 1443-1451
   Abstract »    Full Text »    PDF »
Relevance of Epidemiology to Policies for the Prevention of Cancer.
R. Doll (1985)
Human and Experimental Toxicology 4, 81-96
   PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)